Literature DB >> 15259482

Temporal variations in immune responses to conserved regions of Plasmodium falciparum merozoite surface proteins related to the severity of a prior malaria episode in Gabonese children.

Carsten Köhler1, Anne E Tebo, Beatrice Dubois, Philippe Deloron, Peter G Kremsner, Adrian J F Luty.   

Abstract

We measured cellular and humoral responses to conserved regions of Plasmodium falciparum merozoite surface proteins 1 and 2 (MSP-1 and MSP-2) at different times during and after acute infection in matched groups of Gabonese children who presented with either mild or severe malaria. We used an MSP-1(19) recombinant protein and peptides corresponding to conserved epitopes in MSP-1 and MSP-2 N- and C-terminal regions. The prevalences of peptide-induced cell-mediated responses were maximal in both groups when they were healthy, but were consistently higher in the mild malaria group, whereas peptide-specific antibody responses were consistently highest in the severe malaria group. Recombinant MSP-1(19) protein-specific antibody levels in the 2 groups were similar both prior to and 1 month post-treatment but declined later when the children were healthy and parasite-free, to a significantly lower level in those admitted with severe malaria, reflecting the profile of the predominant MSP-1(19)-specific immunoglobulin G1 isotype. This finding implies a defect in the ability of children with a history of severe malaria to maintain an antibody response putatively associated with immunity to P. falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15259482     DOI: 10.1016/s0035-9203(03)90090-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children.

Authors:  Clarisse L R P Yone; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  Acquired antibodies to merozoite antigens in children from Uganda with uncomplicated or severe Plasmodium falciparum malaria.

Authors:  Hodan Ahmed Ismail; Ulf Ribacke; Linda Reiling; Johan Normark; Tom Egwang; Fred Kironde; James G Beeson; Mats Wahlgren; Kristina E M Persson
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

3.  Chemokine levels and parasite- and allergen-specific antibody responses in children and adults with severe or uncomplicated Plasmodium falciparum malaria.

Authors:  B Wangala; A Vovor; R G Gantin; Y F Agbeko; C J Lechner; X Huang; P T Soboslay; C Köhler
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

4.  The profile of IgG-antibody response against merozoite surface proteins 1 and 2 in severe Plasmodium falciparum malaria in Eastern Sudan.

Authors:  Thoraya M E A-Elgadir; Mustafa I Elbashir; Klavs Berzins; Emad M Masuadi; Ishraga E A-Elbasit; Gehad ElGhazali; Hayder A Giha
Journal:  Parasitol Res       Date:  2007-11-24       Impact factor: 2.289

5.  Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly.

Authors:  Christian J Lechner; Karl Komander; Jana Hegewald; Xiangsheng Huang; Richard G Gantin; Peter T Soboslay; Abram Agossou; Meba Banla; Carsten Köhler
Journal:  Immun Ageing       Date:  2013-07-15       Impact factor: 6.400

6.  Safety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons.

Authors:  Nyamongo Onkoba; Ruth M Mumo; Horace Ochanda; Charles Omwandho; Hastings S Ozwara; Thomas G Egwang
Journal:  J Biomed Res       Date:  2017-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.